Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Singapore's S*BIO Expands Collaboration With Onyx On JAK2 Inhibitors

May 05 2010

• By PharmAsia News

Related Content

Singapore S*BIO Licenses Leukemia Agent SB1317 To U.S.-Based Tragara

Jan 22 2009

Singapore S*BIO Inks "One Of The Biggest" Biotech Deals in Asia With Onyx For JAK2 Inhibitors

Jan 07 2009

On To Phase II Trials For JAK2, Singapore's S*BIO Reports

Dec 09 2009

More from Archive

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window